BACKGROUND
An FEV1/FVC ratio < 0.7 has been widely used to define airflow obstruction, because, on average, it correlates well with more sophisticated measurements of expiratory flow limitation. In fact, the cut-off point of 0.7 is at the core of the definition of COPD according to the GOLD. 1 It follows that most physicians assume that a post-bronchodilator (BD) FEV1/FVC ratio ≥ 0.7 effectively rules out COPD.
OVERVIEW
A 59-year-old, heavy former smoker (45 pack-years) woman who had complaints of exertional dyspnea (mMRC = 3) received a provisional diagnosis of COPD. Although there was partial improvement with the use of inhaled formoterol (mMRC = 2), she was referred to the pulmonology department for reassessment of diagnosis since her post-BD FEV1/FVC ratio had always been ≥ 0.7 (Figure 1A). Additional lung function tests, however, showed mild gas trapping (↑RV) and moderately ↓DLCO (Figure 1B). Considering that the exertional symptoms of the patient could be a mere reflection of severe deconditioning, a cardiopulmonary exercise test was performed to determine whether there was any evidence that “the lungs” could have explained her breathlessness. As shown in Figure 1C, this was indeed the case: a) dyspnea scores, either as a function of work rate or minute ventilation (⩒E), were typically above the upper limit of normal 2 ; b) there was evidence of critical constraints to tidal volume expansion (Figure 1C, arrow) as tidal volume prematurely reached ≈70% of the inspiratory capacity and ≈0.5 L of inspiratory reserve volume, that is, the end-inspiratory lung volume was too close to TLC, 3 and peak ⩒E approached the estimated maximal voluntary ventilation. Moreover, a chest CT showed emphysema and thickened bronchial walls (Figure 1D).
Figure 1. Physiological and structural investigations in a 59-year-old, former heavy smoker woman with complaints of chronic dyspnea. There was a proportional reduction in FEV1 and FVC, leading to a preserved pre- and post-bronchodilator FEV1/FVC ratio (in A), increased RV and reduced DLCO (in B), mechanical ventilatory limitation to exercise (in C; see text for further elaboration), and emphysema plus thickened airway walls on a chest CT (in D) that jointly indicate the presence of COPD. BD: bronchodilator; FRC: functional residual capacity; eMVV: estimated maximal voluntary ventilation; ⩒E: minute ventilation; ⩒O2: oxygen uptake; and VT: tidal volume.

Although there is ongoing controversy regarding the best cut-off point to define airflow obstruction (a fixed FEV1/FVC ratio < 0.7 or age- and sex-based lower limit of normal), a reduced FEV1/FVC ratio has been considered an indispensable criterion for the diagnosis of COPD. 1 There is mounting evidence that subjects showing intermediate FEV1/FVC ratios (i.e., greater than the lower limit of normal but smaller than 0.7) have higher hospitalization and death rates, 1 more cardiovascular comorbidities, and worse exercise tolerance and dyspnea 4 than do subjects with no obstruction using both criteria. Occasionally, however, FVC decreases roughly in tandem with FEV1 as RV increases despite a preserved TLC, reflecting increased small airway collapse/closure at low lung volumes during the forced maneuver. 5 In fact, a sizeable number of symptomatic smokers with no spirometric evidence of obstruction may show gas trapping and/or ↓DLCO plus structural changes in keeping with COPD. 1 Indeed, some such individuals may benefit clinically from a more proactive approach toward early treatment with BDs. 1
CLINICAL MESSAGE
The key pathophysiological characteristic of the current definition of COPD (a persistently ↓FEV1/FVC ratio) is not sine qua non in smokers showing gas trapping and/or ↓DLCO and/or emphysema on CT. As such, there is a surge of interest in adding CT variables to the definition of COPD, 1 although we strongly believe that the abovementioned physiological variables should also be taken into consideration. The bottom line is that the diagnosis of COPD in subjects with a high pre-test probability of the disease but a preserved FEV1/FVC ratio requires a more holistic approach, involving assessment of clinical (dyspnea), physiological (lung volumes and DLCO), and anatomical (emphysema) abnormalities.
REFERENCES
- 1.Han MK, Agusti A, Celli BR, Criner GJ, Halpin DMG, Roche N, et al. From Gold 0 to Pre-COPD. Am J Respir Crit Care Med. 2020 doi: 10.1164/rccm.202008-3328PP. doi: 10.1164/rccm.202008-3328PP. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Neder JA, Berton DC, Nery LE, Tan WC, Bourbeau J. O'Donnell DE A frame of reference for assessing the intensity of exertional dyspnoea during incremental cycle ergometry. Eur Respir J. 2020;56(4):2000191–2000191. doi: 10.1183/13993003.00191-2020. [DOI] [PubMed] [Google Scholar]
- 3.Marillier M, Bernard AC, Gass R, Berton DC, Verges S. O'Donnell DE Are the "critical" inspiratory constraints actually decisive to limit exercise tolerance in COPD . ERJ Open. Res. 2020;6(3):00178–02020. doi: 10.1183/23120541.00178-2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Neder JA, Milne KM, Berton DC. de-Torres JP.Jensen D.Tan WC Exercise Tolerance according to the Definition of Airflow Obstruction in Smokers. Am J Respir Crit Care Med. 2020;202(5):760–762. doi: 10.1164/rccm.202002-0298LE. [DOI] [PubMed] [Google Scholar]
- 5.Berton DC, Neder JA. Measuring slow vital capacity to detect airflow limitation in a woman with dyspnea and a preserved FEV1/FVC ratio. J Bras Pneumol. 2019;45(2):e20190084. doi: 10.1590/1806-3713/e20190084. [DOI] [PMC free article] [PubMed] [Google Scholar]
